(Q43198903)

15 November 2017

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial (English)

1 reference

15 November 2017

Elvin Kedhi

1

1 reference

15 November 2017

Kaiyum Sheik Joesoef

2

1 reference

15 November 2017

Eugene McFadden

3

1 reference

15 November 2017

Jochem Wassing

4

1 reference

15 November 2017

Carlos van Mieghem

5

1 reference

15 November 2017

Dick Goedhart

6

1 reference

15 November 2017

Pieter Cornelis Smits

7

1 reference

15 November 2017

language of work or name

English

0 references

publication date

7 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

375

1 reference

15 November 2017

9710

1 reference

15 November 2017

201-209

1 reference

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

15 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Endothelial cell recovery between comparator polymer-based drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962127-9

7 January 2021

10.1016/S0140-6736(09)62127-9

Identifiers

DOI

1 reference

release_5rzv3uszy5ardgn3nyhxdwr2vy

15 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5rzv3uszy5ardgn3nyhxdwr2vy

24 November 2022

mapped directly with Wikidata item

1 reference